Table 2.
Histologic features of the NAFLD patients.
| Factor | Total (N = 114) | No fibrosis (F0) (N = 63) | Fibrosis (F1–3) (N = 51) | p-value |
|---|---|---|---|---|
| Steatosis | 0.000† | |||
| < 5% | 57 (50.0) | 45 (71.4) | 12 (23.5) | |
| 5–33% | 42 (36.8) | 18 (28.6) | 24 (47.1) | |
| 34–65% | 12 (10.5) | 0 (0.0) | 12 (23.5) | |
| ≥ 66% | 3 (2.6) | 0 (0.0) | 3 (5.9) | |
| Portal inflammation (under 20 ×) | 0.000† | |||
| None | 51 (44.7) | 45 (71.4) | 6 (11.8) | |
| < 2 | 45 (39.5) | 18 (28.6) | 27 (52.9) | |
| 2–4 | 9 (7.9) | 0 (0.0) | 9 (17.6) | |
| > 4 | 9 (7.9) | 0 (0.0) | 9 (17.6) | |
| Ballooning | 0.000† | |||
| None | 27 (23.7) | 18 (28.6) | 9 (17.6) | |
| Few | 75 (65.8) | 45 (71.4) | 30 (58.8) | |
| Many | 12 (10.5) | 0 (0.0) | 12 (23.5) | |
| NAS§ | 3.29 ± 2.03 | 2.29 ± 1.17 | 4.53 ± 2.19 | 0.000‡ |
Values presented as mean ± standard deviation or N (column %).
NAFLD non-alcoholic fatty liver disease, NAS§ NAFLD activity score.
Fibrosis was scored as F0, no fibrosis; F1, portal fibrosis without septae; F2, portal fibrosis with septae; F3, numerous septae without cirrhosis; and F4, cirrhosis.
NAFLD patients and non-NAFLD patients.
p-values: †Pearson’s chi-squared test, ‡Student's t‐test.